Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 3/2019

01-03-2019 | Letter to the Editor

Glucose variability in PD-1 inhibitors-induced diabetes mellitus

Authors: Francesco Tassone, Elena Gamarra

Published in: Acta Diabetologica | Issue 3/2019

Login to get access

Excerpt

We appreciated the short communication by Marchand et al. [1] and their interest in our case report [2]: these authors stressed the importance of glucose variability in our patient similar to those of their patients reported in their present short communication. …
Literature
1.
2.
Metadata
Title
Glucose variability in PD-1 inhibitors-induced diabetes mellitus
Authors
Francesco Tassone
Elena Gamarra
Publication date
01-03-2019
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1263-3

Other articles of this Issue 3/2019

Acta Diabetologica 3/2019 Go to the issue

Short Communication

Comparison of correlations of equation-derived body fat percentage and body mass index with carotid intima-media thickness

Original Article

A novel role of bone morphogenetic protein 6 (BMP6) in glucose homeostasis

Original Article

Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis

Short Communication

Fulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability?

Letter to the Editor

Reply to comment: Serum bilirubin concentrations, type 2 diabetes, and incident coronary heart disease

Original Article

High intensity interval training protects the heart during increased metabolic demand in patients with type 2 diabetes: a randomised controlled trial

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits